Discover How Portable CMC^®
is Solving the Translational Gap

Ready to see it in action? Let’s meet.

See how effortless it is with Wheeler Bio’s Portable CMC^® innovative platform to align your product development and fundraising timelines exactly to your specific needs. This groundbreaking platform serves as a bridge for translating discoveries into IND filing, enabling innovators to gain added momentum during technology transfer, reduced risk, and modular work packages that are tailored to fit both timelines and budgets seamlessly.

Our open-source approach to developing monoclonal antibodies aims to empower innovators by reducing the risks and costs associated with bringing therapeutics from discovery to the clinic.

We are ready to show you Portable CMC^® in action! By clicking the link below, you can schedule a meeting with one of our C-Suite leaders.